Global, Regional, and National Burden of Alopecia Areata in Children and Adolescents Aged 0-19 years from 1990 to 2021 and Projection to 2040

Background: Global epidemiological patterns of alopecia areata in pediatric populations remain inadequately characterized. We evaluated the disease burden and trends among children and adolescents aged 0– 19 years across 204 countries and territories from 1990 to 2021 and projected the disease development from 2022 to 2040. Methods: Using Global Burden of Disease (GBD) 2021 data, we analyzed incidence, prevalence, and disability-adjusted life years (DALYs), stratified by sex, age, and Sociodemographic Index (SDI). Temporal trends were quantified via estimated annual percentage changes (EAPC) in age-standardized rates. The Bayesian age cohort model was used to predict prevalent cases trend from 2022 to 2040. Results: In 2021, global prevalent cases increased by 15.79% (1990– 2021), yet age-standardized incidence (ASIR), prevalence (ASPR), and DALY rates (ASDR) declined significantly (EAPC range: − 0.092 to − 0.099). Females consistently bore 75% higher burden than males. Disease metrics escalated with age, peaking in the 15– 19 age subgroup. Low-SDI group exhibited rising ASIR/ASPR/ASDR (EAPC up to 0.050), contrasting declines in higher-SDI areas. High-income North America recorded the highest ASPR (145.84/100,000) but the most rapidly decline (EAPC=− 0.251), while Central Sub-Saharan Africa showed the steepest increases. India reported the highest national prevalent cases (420,913) in 2021. The disease burden of alopecia areata among children and adolescents aged 0– 19 years worldwide and in India will tend to be stable from 2022 to 2040, while the disease burden in China will rise, and in the United States of America, it will continue to decline. Conclusion: Despite a decrease in the relative burden, the absolute number of alopecia areata cases rose globally. Critical disparities persist among females, adolescents (15– 19 years), and low-SDI populations—particularly in Central Sub-Saharan Africa. Targeted interventions for these vulnerable groups are urgently needed. Keywords: alopecia areata, global burden of disease, incidence, prevalence, disability-adjusted life years, children and adolescents

Authors

Institutions

Publication Details

Journal
Clinical Cosmetic and Investigational Dermatology
Published
2026-02-01
DOI
https://doi.org/10.2147/ccid.s582775
Citations
1
Primary Topic
Hair Growth and Disorders
Type
article
Field-Weighted Citation Impact
41.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global, Regional, and National Burden of Alopecia Areata in Children and Adolescents Aged 0-19 years from 1990 to 2021 and Projection to 2040

Hongzheng Lu, L F Li, Ke Ma, B Zhang et al.
1 citations
Clinical Cosmetic and Investigational Dermatology
Hair Growth and Disorders
41.56
article

Global, Regional, and National Burden of Alopecia Areata in Children and Adolescents Aged 0-19 years from 1990 to 2021 and Projection to 2040

Hongzheng Lu, L F Li, Ke Ma, B Zhang, Jinbo Li, TingTing Wang, Shengchun Wang
article en
1 citations

Abstract

Background: Global epidemiological patterns of alopecia areata in pediatric populations remain inadequately characterized. We evaluated the disease burden and trends among children and adolescents aged 0– 19 years across 204 countries and territories from 1990 to 2021 and projected the disease development from 2022 to 2040. Methods: Using Global Burden of Disease (GBD) 2021 data, we analyzed incidence, prevalence, and disability-adjusted life years (DALYs), stratified by sex, age, and Sociodemographic Index (SDI). Temporal trends were quantified via estimated annual percentage changes (EAPC) in age-standardized rates. The Bayesian age cohort model was used to predict prevalent cases trend from 2022 to 2040. Results: In 2021, global prevalent cases increased by 15.79% (1990– 2021), yet age-standardized incidence (ASIR), prevalence (ASPR), and DALY rates (ASDR) declined significantly (EAPC range: − 0.092 to − 0.099). Females consistently bore 75% higher burden than males. Disease metrics escalated with age, peaking in the 15– 19 age subgroup. Low-SDI group exhibited rising ASIR/ASPR/ASDR (EAPC up to 0.050), contrasting declines in higher-SDI areas. High-income North America recorded the highest ASPR (145.84/100,000) but the most rapidly decline (EAPC=− 0.251), while Central Sub-Saharan Africa showed the steepest increases. India reported the highest national prevalent cases (420,913) in 2021. The disease burden of alopecia areata among children and adolescents aged 0– 19 years worldwide and in India will tend to be stable from 2022 to 2040, while the disease burden in China will rise, and in the United States of America, it will continue to decline. Conclusion: Despite a decrease in the relative burden, the absolute number of alopecia areata cases rose globally. Critical disparities persist among females, adolescents (15– 19 years), and low-SDI populations—particularly in Central Sub-Saharan Africa. Targeted interventions for these vulnerable groups are urgently needed. Keywords: alopecia areata, global burden of disease, incidence, prevalence, disability-adjusted life years, children and adolescents

Clinical Cosmetic and Investigational DermatologyVol. Volume 19
Shenyang Pharmaceutical University (CN), Shanxi Medical University (CN), Zhengzhou Children's Hospital (CN), Nobel Foundation (SE), Beijing Children’s Hospital (CN)
No poverty
Openalex Percentile: Top 1%
Hair Growth and Disorders
41.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.